ClickCease Shungite CONCLUSIVE DECISION concerning application
Home Blog CONCLUSIVE DECISION concerning application of shungite paste, ointment and suspension for external t ...

Tuesday, 12 May 2015 15:16

CONCLUSIVE DECISION concerning application of shungite paste, ointment and suspension for external therapy

Rate this item
(0 votes)

The First Leningrad Institute of Medicine

Saint Petersburg Medical Institute of

Hygiene and Sanitation

Department of dermatovenereology

(Head of department prof. M.E. Starchenko)



concerning application of shungite paste, ointment and suspension for external therapy


The goal of the present research was effectiveness study of shungite suspension in the form of stupes, shungite paste and ointment using for outward application.

The group of patients (53) who suffered from various forms of allergodermathosis, psoriasis and erythema centrifugum was formed. The biggest group to the number of 23 persons consisted of patients with eczema. Almost all the patients had severe, capricious and torpid progression of the disease in past medical history.

The II study group consisted of patients with atopic dermatosis (neurodermatitis disseminata) to the number of 9 persons. All the patients had severe recurrent progression of the disease with evident severe skin itching. It is really difficult to select an external therapy for such patients because there is intolerance to many medications in this case.

The third study group to the number of 15 persons was composed of patients who suffered from psoriasis exudativa and psoriasis with apparent large infiltrated plaques; three patients suffered from seborrhea congestiva.

There were 53 patients under the care of physicians in total. They were from 18 to 80 years old but the largest group was 30-50 years old. There were 21 females and 32 males among them.

SHUNGITE SUSPENSION was used for patient curing who suffered from severe skin disease process followed by apparent water thesaurismosis, erythema; and some of patients suffered from madescence.

There were 23 patients under observation, 16 persons among them had eczema in the exacerbation phase with apparent microvesiculation; 5 of them had atopic dermatosis (neurodermatitis disseminata); 2 of them had nasty form of madidans psoriasis exudativa. All the patients without any exception complained of severe itching.

Shungite suspension was used in the form of soaking therapy and wet-to-dry dressings at a dilution of 1:3. Dressings were changed 3-4 times throughout the day. All the patients noticed subsidence of itching first and then itching disappearance. Within first 2-3 days stopping of madescence and water thesaurismosis were noticed; alloeosis – 3,   mend – 17, without action – 3. Later 20 patients were treated by SHUNGITE PASTE. We used 25% shungite based on zinc paste. There were 32 patients under observation with diagnosis: eczema – 17 persons, atopic dermatosis (neurodermatitis disseminata) – 6, psoriasis – 6, seborrhea congestiva – 3 persons.

7 patients who suffered from eczema had multivalent hypersensitivity to external therapy, intolerance to many medications (wood tar, naphthalan, basic bismuth gallate, boric acid, salicylic acid). Patients with eczema and atopic dermatosis complained of severe itching that remained even under pressure of hyposensitization therapy.

Shungite paste was well tolerated by all the patients. They noticed itching subsidence and then its total disappearance. Erythema, water thesaurismosis disappeared by 5th-7th day of shungite paste using. Patients with eczema had specific impact caused by conducted therapy. Favourable evolution (itching disappearance; flattening of papules, plaques; peeling disappearance) was noticed in psoriasis case. Specific impact was noticed in case of 3 patients with seborrhea congestiva. Erythema and acanthokeratodermia retracted thanks to  external therapy conducted in association with constitutional therapy. Alloeosis – 20,   mend – 12, without action – non.

25% SHUNGITE OINTMENT (base is petrolate) was used for curing of chronic patients (18), 6 of them had eczema, 3 of them had atopic dermatosis (neurodermatitis disseminata), 9 of them had psoriasis.

There were signs of apparent chronic inflammation (infiltration, fissures) on the skin of the patients. All of them complained of severe itching. During first day 83% of patients didn’t suffer from itching, after 7-10 days infiltration was solved almost completely in patients who had eczema and neurodermia; psoriasis plaques flattened considerably. Alloeosis – 6,   mend – 10, without action – 2.

Therefore alloeosis was noticed in 29 patients what is equal to 54,7 % in patient group (53) studied by us. Generally this number included patients who suffered from allergodermathosis (eczema, atopic dermatosis).

Mend was noticed in 19 patients (it was equal to 35,8%). Patients with atopic dermatosis, psoriasis and seborrhea congestiva were included in study group.

Action from conducted therapy didn’t occur in 2 patients with atopic dermatosis which amounted to 9,5%.

Synthesis and analysis of obtained results allows us to arrive at the conclusion that shungite suspension, paste and ointment: 1) are nonhazardous dermatics with apparent antihistaminic and anti-inflammatory action which eliminates itching and skin disorder. 2) don’t have an adverse affect; no complications were noticed during treatment.

Thus obtained results prove effectiveness of shungite suspension, paste and ointment for external therapy of patients suffered from allergodermathosis, psoriasis and seborrhea congestiva. They exhibit apparent anti-inflammatory properties (eliminate itching, inflammation) and could be used for external treatment of patients with skin conditions.



Head of department

prof. Doctor of Medicine                          Starchenko M.E.


Associate professor

Candidate of Medical Science                  Piryatinskaya V. A.


Resident Medical Practitioner                  Lytaeva E. A.



Stamp                                       Signatures          


Read 5744 times Last modified on Monday, 14 March 2016 12:42